Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salivary Concentration of Cetylpyridinium Chloride Buccal Tablets
NCT05802628Phase 4Completed
- Sponsor
- Peking University People's Hospital
- Start
- Apr 2023
- Primary completion
- Apr 2023
- Modality
- Conventional Liposomes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cetylpyridinium chloride in gingivitis, acute pharyngitis, sponsored by Peking University People's Hospital. Started Apr 2023; status: completed.
02
Drugs
cetylpyridinium chloride
03
Conditions
gingivitisacute pharyngitis
Beyond the preview
Go deeper on NCT05802628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05802628.